CPT code 69801 designates a surgical incision into the labyrinth with instillation or perfusion of one or more drugs (for example, steroids or antibiotics) through the tympanic membrane. The code captures a targeted otologic procedure used to deliver medications directly into the inner ear when topical or systemic therapy is insufficient. Nationally, this code matters for otolaryngology practice patterns, facility billing, and payers managing coverage for specialized inner-ear interventions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a clinical context for when intralabyrinthine drug instillation is performed, typical sites of service, common billing modifiers and documentation considerations, and related CPT coding guidance. The publication summarizes benchmark payment information where available, highlights relevant policy and coverage considerations that affect access to intralabyrinthine treatments, and outlines documentation elements frequently reviewed in claims adjudication.

This summary is intended to provide clinicians, coding professionals, and policy stakeholders a concise reference to CPT code 69801, its clinical use, and the payer landscape relevant to billing and coverage for intralabyrinthine drug instillation.